Literature DB >> 12221212

Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients.

Petra G Boelens1, Alexander P J Houdijk, Johanna C M Fonk, Robert J Nijveldt, Charlotte C Ferwerda, B Mary E Von Blomberg-Van Der Flier, Lambertus G Thijs, Henk J Th M Haarman, Juan C Puyana, Paul A M Van Leeuwen.   

Abstract

The aim of this study was to investigate the effect of glutamine-(Gln)-enriched enteral nutrition (EN) on human leukocyte antigen (HLA)-DR and FcgammaR1/CD64 expression on monocytes and plasma glutamine concentrations in multi-trauma patients. HLA-DR expression on monocytes is crucial in the presentation of foreign antigen to the immune system and is severely reduced in trauma patients. In vitro monocyte HLA-DR and FcgammaRI/CD64 expression is dependent on glutamine availability. To study the effect of glutamine supplemented enteral nutrition on HLA-DR and FcgammaRI/CD64 expression on CD14(+) monocytes, 55 multi-trauma patients were studied in a randomized, double-blinded, controlled trial. Trauma patients received either a Gln-enriched EN (glutamine group, n = 28) or an isocaloric, isonitrogenous control EN (control group, n = 27) and were compared with a group of age-matched healthy volunteers (healthy volunteers, n = 53). On d 1, 5, 9 and 14 after trauma, expressions of HLA-DR and FcgammaRI/CD64 were determined on CD14(+) monocytes using FACS analysis. Plasma glutamine levels were measured using HPLC. Plasma glutamine was lower in both trauma patient groups compared with healthy volunteers and from d 3 to d 5; glutamine was higher in the glutamine group than in the control group. On d 1, HLA-DR expression was much lower in both trauma patient groups than in healthy volunteers. HLA-DR expression was greater on d 5, 9 and 14 in the glutamine group than in the control group. FcgammaRI/CD64 expression on monocytes of trauma patients was not different than the expression of healthy volunteers. This study showed that glutamine-enriched enteral nutrition was associated with a higher HLA-DR expression on CD14(+) monocytes of trauma patients. No difference in monocyte FcgammaRI/CD64 expression was detected between patients that received the two enteral diets and between trauma patients and the healthy volunteers. Increased HLA-DR expression may improve cellular immune function and may be involved in the beneficial effect of glutamine on the occurrence of infections in trauma patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221212     DOI: 10.1093/jn/132.9.2580

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  14 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

2.  Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial.

Authors:  Marcel J I J Albers; Ewout W Steyerberg; Frans W J Hazebroek; Marjan Mourik; Gerard J J M Borsboom; Trinet Rietveld; Jan G M Huijmans; Dick Tibboel
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

3.  Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells.

Authors:  Sandra Lechowski; Katharina Feilhauer; Ludger Staib; Moïse Coëffier; Stephan C Bischoff; Axel Lorentz
Journal:  Eur J Nutr       Date:  2012-04-20       Impact factor: 5.614

4.  Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.

Authors:  P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Authors:  Jon Pérez-Bárcena; Pedro Marsé; Arturo Zabalegui-Pérez; Esther Corral; Rubén Herrán-Monge; María Gero-Escapa; Mercedes Cervera; Juan Antonio Llompart-Pou; Ignacio Ayestarán; Joan Maria Raurich; Antonio Oliver; Antonio Buño; Abelardo García de Lorenzo; Guiem Frontera
Journal:  Intensive Care Med       Date:  2014-02-21       Impact factor: 17.440

6.  Influence of surgical intervention in the immune response of severely injured patients.

Authors:  Sascha Flohé; Sven Lendemans; Fritz-Ulrich Schade; Ernst Kreuzfelder; Christian Waydhas
Journal:  Intensive Care Med       Date:  2003-11-07       Impact factor: 17.440

7.  Glutamine supplemented parenteral nutrition to prevent ventilator-associated pneumonia in the intensive care unit.

Authors:  Meltem Türkay Aydoğmuş; Yakup Tomak; Murat Tekin; Ismail Katı; Urfettin Hüseyinoğlu
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

Review 8.  Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.

Authors:  S Flohé; S B Flohé; F U Schade; C Waydhas
Journal:  Langenbecks Arch Surg       Date:  2007-06-29       Impact factor: 3.445

9.  Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.

Authors:  Menghua Luo; Niloofar Bazargan; Daniel P Griffith; Concepción F Estívariz; Lorraine M Leader; Kirk A Easley; Nicole M Daignault; Li Hao; Jon B Meddings; John R Galloway; Jeffrey B Blumberg; Dean P Jones; Thomas R Ziegler
Journal:  Clin Nutr       Date:  2008-02-07       Impact factor: 7.324

10.  Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.

Authors:  Ruqaiya M Al Balushi; Jennifer D Paratz; Jeremy Cohen; Merrilyn Banks; Joel Dulhunty; Jason A Roberts; Jeffrey Lipman
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.